Search
for
Sort by
Research 241–270 of 1000+
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Beau’s Lines and COVID-19; A Systematic Review on Their Association
- Stem-cell therapy in dermatology – Challenges and opportunities
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Stress and the Hair Follicle
- Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Feline Non-Flea Induced Hypersensitivity Dermatitis
- Alopecia areata: Part 2: treatment.
- Role of nutritional supplements in selected dermatological disorders: A review
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
- Treatment of pediatric alopecia areata: A systematic review
- The Scientific Legacy of Stephen Rothman
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Erythema Nodosum Associated with Kerion: A Case Series and Narrative Review of the Literature
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Forsythiae Fructus: A Review on its Phytochemistry, Quality Control, Pharmacology and Pharmacokinetics
- Utility of dermoscopy in alopecia areata
- Alopecia areata: a new treatment plan
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Dimensionality and psychometric analysis of DLQI in a Brazilian population
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- The Link Between Obesity and the Skin
- Female pattern hair loss—An update
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial